What does Akkermansia actually do in your body?
Akkermansia muciniphila is a bacterium that naturally lives in the mucus layer of your gut. It feeds on mucus and produces short-chain fatty acids (SCFAs) like butyrate and acetate, which are key signals for your immune system and metabolism [4][12]. Think of it as a gatekeeper: it helps maintain the gut barrier, reduces low-grade inflammation, and influences how your body handles sugar and fat [5][9].
In animal models, supplementing with Akkermansia—especially the pasteurized (heat-killed) form—has shown a wide range of benefits. For example, in mice with antibiotic-associated diarrhea, pasteurized Akkermansia reduced diarrhea severity, lowered gut inflammation (by decreasing TNFα, IFNγ, IL1β, and IL6), and restored the gut barrier by upregulating tight junction proteins like ZO-1 and occludin [2]. In zebrafish with both diabetes and Alzheimer's-like symptoms, pasteurized Akkermansia improved blood glucose, body mass index, and memory-related behaviors [3]. And in mice fed a high-fat diet, Akkermansia prevented weight gain and fatty liver, partly by increasing the abundance of beneficial bacteria like Prevotellaceae [6].
The catch: context matters a lot
Akkermansia is not a universal 'good guy'—its effects depend heavily on what else is going on in your gut. A key study using a 14-member synthetic human gut microbiota in mice found that when mice were fed a fiber-free diet, Akkermansia actually made them more susceptible to a gut pathogen (Citrobacter rodentium) by eroding the mucus barrier [11]. But when the same mice ate a fiber-rich diet, Akkermansia protected against the infection [11]. This means that if you take Akkermansia without also eating enough dietary fiber, you might be doing more harm than good.
The form of Akkermansia also matters. Multiple studies show that pasteurized (heat-killed) Akkermansia is often more effective than live bacteria for improving metabolic markers and gut barrier function [8][10]. In normal-diet-fed mice, pasteurized Akkermansia had a stronger effect on reducing body weight, liver fat, and inflammation than the live version [8]. This is important because pasteurized Akkermansia is easier to store and standardize as a supplement.
And the evidence is still mostly from animals. The only large human trial in this set—a randomized controlled trial of 34,601 adults testing cod liver oil (a different supplement)—found no benefit for preventing COVID-19 or other respiratory infections [1]. That doesn't directly test Akkermansia, but it's a reminder that promising animal results don't always translate to humans.
Where might Akkermansia fit into preventive medicine?
Based on the evidence here, the most plausible preventive uses for Akkermansia are in metabolic health and gut-related conditions. For example, in mice, Akkermansia prevented the negative effects of dietary emulsifiers (common food additives) on metabolism and gut inflammation [7]. It also protected against antibiotic-associated diarrhea by restoring gut barrier function [2] and reduced liver steatosis (fatty liver) when given alongside inulin, a prebiotic fiber [6].
There's also early evidence for brain health. In sleep-deprived mice, Akkermansia supplementation prevented cognitive decline and synaptic loss by increasing SCFAs and calming microglial activation in the brain [4]. And in zebrafish with both diabetes and Alzheimer's, it improved memory and anxiety-like behaviors [3]. These are animal models, but they suggest a potential role in preventing neurodegeneration linked to metabolic dysfunction.
The bottom line for a person considering Akkermansia supplementation: it's not yet a proven preventive medicine for humans, but the science is moving fast. If you have metabolic issues (obesity, prediabetes, fatty liver) or gut problems (post-antibiotic recovery, IBS), it might be worth discussing with a doctor—but only if you also maintain a fiber-rich diet. Without fiber, Akkermansia could backfire [11].
About These Sources
This answer is built on 12 peer-reviewed studies — published from 2021 to 2025, 4 from 2024 or later, 7 in Q1 journals, collectively cited 516 times — selected as the most relevant from 15 studies that passed quality screening, drawn from 72 papers retrieved from a database of over 500 million.
Sources used in this answer
Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial
In a large randomized controlled trial of 34,601 adults, daily cod liver oil (low-dose vitamin D) did not reduce the risk of SARS-CoV-2 infection, serious COVID-19, or other acute respiratory infections compared to placebo.
Akkermansia muciniphila Protects Against Antibiotic-Associated Diarrhea in Mice
In mice with antibiotic-associated diarrhea, pasteurized Akkermansia or its protein Amuc_1100 reduced diarrhea severity, gut inflammation (TNFα, IFNγ, IL1β, IL6), and restored gut barrier function (ZO-1, occludin, claudin-4).
Improvement in Zebrafish with Diabetes and Alzheimer's Disease Treated with Pasteurized Akkermansia muciniphila
In zebrafish with both type 2 diabetes and Alzheimer's disease, pasteurized Akkermansia improved blood glucose, body mass index, and memory-related behaviors; preventive treatment was more effective than therapeutic.
<i>Akkermansia muciniphila</i> supplementation prevents cognitive impairment in sleep-deprived mice by modulating microglial engulfment of synapses
In sleep-deprived mice, Akkermansia supplementation prevented cognitive decline and synaptic loss by increasing short-chain fatty acids (acetate, butyrate) and reducing microglial engulfment of synapses.
Akkermansia muciniphila: A Potential Target for the Prevention of Diabetes
A review of the literature concludes that Akkermansia and its components (Amuc_1100, extracellular vesicles, proteins P9 and Amuc_1409) show promise for preventing and treating diabetes through multiple mechanisms.
Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level
In mice fed a high-fat diet, the prebiotic inulin increased Akkermansia abundance by 5-fold and prevented liver steatosis, suggesting Akkermansia mediates some of inulin's metabolic benefits.
<i>Akkermansia muciniphila</i> counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism
In mice, daily oral Akkermansia prevented the metabolic and inflammatory effects of dietary emulsifiers (CMC and P80), including weight gain, dysglycemia, and gut microbiota encroachment.
Comparative effects of alive and pasteurized Akkermansia muciniphila on normal diet-fed mice
In normal-diet-fed mice, both live and pasteurized Akkermansia improved metabolic and immune markers, but pasteurized Akkermansia had stronger effects on gut barrier integrity and inflammation.
Akkermansia muciniphila, a New Generation of Beneficial Microbiota in Modulating Obesity: A Systematic Review
A systematic review of 10 animal studies concluded that Akkermansia supplementation modulates obesity by improving insulin sensitivity, glucose homeostasis, and reducing low-grade inflammation.
Supplementation with Akkermansia muciniphila improved intestinal barrier and immunity in zebrafish (Danio rerio).
In zebrafish fed a high-fat diet, both live and pasteurized Akkermansia increased intestinal villi length, upregulated tight junction genes (claudin, occludin), and reduced pro-inflammatory cytokines.
Diet-driven differential response of Akkermansia muciniphila modulates pathogen susceptibility
Using a 14-member synthetic human gut microbiota in mice, Akkermansia increased susceptibility to Citrobacter rodentium infection on a fiber-free diet but protected against infection on a fiber-rich diet.
Akkermansia muciniphila: The role as a probiotic bacteria for the prevention and treatment of metabolic syndrome
A review concludes that Akkermansia is a promising probiotic for metabolic syndrome, as it increases intestinal mucus thickness and produces short-chain fatty acids that improve host inflammatory status.